Patent Yard Sign in
Canadian application, no grantCanada

St. john's wort and methyl donor composition and uses thereof

CA 2317671 A1 · Owner: Rexall Sundown, Inc. · Inventors: Fotouhi, Nader; Desantis, Debbie A.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A therapeutic composition and method are provided for mood enhancement regulation and the treatment of depression and anxiety and the relief of PMS , associated symptoms in mammals. The composition comprises St. John's Wort (Hypericum perforatum) and a methyl donor such as S-adenosylmethionine.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 13, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 13, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 13, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 13, 1999
GrantedNo grant recorded
Term endedJanuary 13, 2019
Patent numberCA 2317671 A1
Classification (IPC)A61K31/70 +2 more

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedJan 13, 1999Term endedJan 13, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.